Congress Sessions

Keynote Session 4 – Novel Lab Technologies

Keynote Session 4 – Novel lab technologies Digital Transformation and Drug Discovery Christopher Langmead, Executive Director and Head of Digital Biologics Discovery, Amgen Empowering the Future of Collaborative, Digital Drug Discovery – From Small to Large Molecules Erin Davis, SVP Enterprise Informatics, Schrodinger LLMs and Liquid Handlers and GPTs, Oh My! Lab Automation in the Age... Read more →

Keynote Session 3 – Creating a Connected Ecosystem

Moderator’s Introduction Michael Shanler, VP Distinguished Analyst, Gartner Unlocking the Power of the Proteome in... Read more

Keynote Session 2 – Supporting innovation in Biopharma R&D

Moderator’s Introduction Michael Shanler, VP Distinguished Analyst, Gartner Collaboration as the key to delivering the... Read more

Keynote Session 1 – Digital Transformation in the Lab of the Future

Moderator’s Introduction Greg Moody, R&D IT Business Leader The Digital Transformation Journey – Are we... Read more